Jim Simons
MRVI icon

Jim Simons’s Maravai LifeSciences MRVI Stock Holding History

Jim Simons’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Buy
4,264,689
+39,600
+0.9% +$134K 0.02% 878
2025
Q4 		$13.7M Sell
4,225,089
-93,000
-2% -$313K 0.02% 771
2025
Q3 		$12.4M Buy
4,318,089
+131,900
+3% +$337K 0.02% 981
2025
Q2 		$10.1M Buy
4,186,189
+75,500
+2% +$159K 0.01% 1052
2025
Q1 		$9.08M Buy
4,110,689
+138,500
+3% +$547K 0.01% 1053
2024
Q4 		$21.6M Sell
3,972,189
-166,286
-4% -$1.07M 0.03% 637
2024
Q3 		$34.4M Buy
4,138,475
+257,034
+7% +$2.22M 0.05% 450
2024
Q2 		$27.8M Buy
3,881,441
+668,552
+21% +$5.77M 0.05% 470
2024
Q1 		$27.9M Buy
3,212,889
+327,200
+11% +$2.21M 0.04% 496
2023
Q4 		$18.9M Buy
2,885,689
+226,000
+8% +$1.46M 0.03% 637
2023
Q3 		$26.6M Buy
2,659,689
+218,514
+9% +$2.4M 0.05% 454
2023
Q2 		$30.3M Sell
2,441,175
-751,325
-24% -$10.1M 0.04% 487
2023
Q1 		$44.7M Sell
3,192,500
-134,448
-4% -$1.93M 0.06% 385
2022
Q4 		$47.6M Buy
3,326,948
+1,804,248
+118% +$28.4M 0.07% 351
2022
Q3 		$38.9M Sell
1,522,700
-352,300
-19% -$8.84M 0.06% 396
2022
Q2 		$53.3M Buy
1,875,000
+961,800
+105% +$30.5M 0.06% 346
2022
Q1 		$32.2M Buy
913,200
+368,400
+68% +$12.3M 0.04% 513
2021
Q4 		$22.8M Sell
544,800
-405,281
-43% -$16.4M 0.03% 641
2021
Q3 		$46.6M Buy
950,081
+305,281
+47% +$14.9M 0.06% 327
2021
Q2 		$26.9M Buy
+644,800
New +$25M 0.03% 584

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jim Simons's MRVI Position: Q1 2026 in Review

Jim Simons increased its Maravai LifeSciences (MRVI) stake by 0.94% in Q1 2026, buying an estimated $134K and bringing the position to 4,264,689 shares worth $12.1M. The position accounts for 0.02% of the portfolio, ranked #878.

Jim Simons first reported a position in MRVI in Q2 2021 and has held it in 20 quarters since. The position peaked at $53.3M in Q2 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Jim Simons held 4,264,689 shares of Maravai LifeSciences worth $12.1M as of Q1 2026.
  • Jim Simons bought 39,600 Maravai LifeSciences shares in Q1 2026, an estimated $134K.
  • Maravai LifeSciences made up 0.02% of Jim Simons's portfolio in Q1 2026, its #878 holding.
  • Jim Simons first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 20 quarters since.
  • Jim Simons's Maravai LifeSciences position peaked at $53.3M in Q2 2022.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.